We deal with:
We turn to:
APR Italy is the Italian branch of the Swiss headquarter, the heart and brain of all research and development activities.
APR is a Swiss, independent developer of healthcare products. The company identifies, develops and licenses science-driven, value-added products designed to address patient or consumer needs in niche or rare therapeutic areas on a global basis. The company has a dedicated and experienced Pharmaceutical R&D Team focused on innovation in healthcare and a strong formulation and development knowhow, coupled with an extensive regulatory experience in EU and US. APR has a balanced pipeline of revenue generating branded products marketed in all major markets, combined with a compelling pipeline of innovative products at different stages of development. APR provides a wide range of R&D services for the pharmaceutical and pharmacological industry on a contract basis such as development of oral and topical formulation and drug delivery technologies. APR has entered into licensing and healthcare partnership agreements with pharmaceutical companies in over 70 countries with international sales on a worldwide basis.